Neuraxis ends Masimo partnership on NSS-2 Bridge; pays $200K, forfeits future royalties

Neuraxis, INC

Terminated License and Collaboration Agreement with Masimo Corp., effective July 1, 2025.
Neuraxis to pay Masimo $200,000 in two installments (Dec 2025 and Jun 2026) for trademarks, patents, and inventory.
Neuraxis will no longer receive any licensing payments or revenue from the NSS-2 Bridge device.
Adopted 2025 Employee Stock Purchase Plan, offering 100,000 shares at 15% discount.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.